MEBIAS Discovery LLC Presents Pre-Clinical Data on MU Opioid Receptor Pain Compounds at ADDC

By WebmasterOctober 16, 2017November 1st, 2024No Comments

MEBIAS Discovery LLC Presents Pre-Clinical Data on MU Opioid Receptor Pain Compounds at ADDC

Previous PostBioBots adopts new name, launches new software
Next PostIntezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development